You are here: MEDICA Portal. Magazine & More. MEDICA Magazine. Interviews. Interviews.
Current interview: Direct-To-Consumer Testing
The many possibilities the Internet offers also don’t shy away from laboratory medicine. The demand for biochemical or genetic tests continues to rise. Next to standard laboratory tests, a market developed in which the patient is the immediate recipient of clinical results. New distribution channels eliminate the physician as the responsible party.
MEDICA.de spoke with adjunct professor Dr. Matthias Orth, MD, Head of Laboratory Medicine at the Marienhospital in Stuttgart, about the risks of direct-to-consumer testing.
3 questions to ... Jennifer Goldenstede, SPECTARIS e.V.
The Ukrainian political turmoil has been keeping the world in suspense since 2013. It has also caused growing tensions between Russia on the one hand and the U.S. and EU on the other hand. Both sides try to pressure each other with sanctions against individuals, international financial transactions and whole industry branches.
In the interview with MEDICA-tradefair.com, Jennifer Goldenstede talks about exports of medical technology to Russia and explains the trade sanctions' impact on the industry.
Interviews Concerning Health Politics
Health is human's most precious resource. Due to the fact that this applies to every individual health care politics become to an interesting and sometimes quite explosive topic. MEDICA.de talks to managers, politicians and other experts about current political decisions and happenings.Click here for the interviews!
What is happening on the market for medical products? Important technologies, national and international markets, news from companies - all these topics are important subjects when MEDICA.de talks to experts about current developments in business concerned with health.Click here for the interviews!
Interviews Concerning Innovations
Discoveries, devices, technologies - medicine is an important driving force behind myriads of innovations. Experts and inventors provide information about potentials and sometimes risks concerned with new treatments while talking to MEDICA.de.Here are the Innovation Interviews